Pure Global AI
NCT06131931Recruiting

HIV Prevention Intervention for Latino Male Couples

Connecting Latinos en Pareja: A Couples-based HIV Prevention Intervention for Latino Male Couples
University of Central FloridaClinicalTrials.govother
Verified
Study focus
Disease/Condition
HIV
Drug/Device/Intervention
CLP Intervention
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Central Florida
Location
Orlando, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jun 21, 2023
End date
Jun 01, 2028
Enrollment
400 participants
Primary outcome

HIV Prevention sessions and assessments

Summary

The primary objective of this proposal is to test the efficacy of Connecting Latinxs en
 Pareja (CLP). CLP is a four-session intervention grounded in social cognitive theory and a
 relationship oriented ecological framework.
 
 The investigators will examine whether participants assigned to CLP report an increase in the
 proportion of HIV protected anal sex acts to those assigned to a Wellness Promotion (WP) time
 and attention matched control condition. The primary outcome, relates to use of HIV
 protection.

ICD-10 classifications
Human immunodeficiency virus [HIV] diseaseHuman immunodeficiency virus [HIV] disease resulting in other conditionsHIV disease resulting in other viral infectionsUnspecified human immunodeficiency virus [HIV] diseaseHuman immunodeficiency virus [HIV] disease resulting in other specified diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06131931
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06131931 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Central Florida and is currently Recruiting. The study focuses on HIV. Target enrollment is 400 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.